Bare Medical Spa + Laser Center
Bare Medical Spa + Laser Center · 100 Bank St # 700 · Burlington, VT 05401
4.8· 384 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
About this practice
Bare Medical Spa + Laser Center is a medical spa in downtown Burlington, Vermont, whose website describes injectables such as Juvederm, Restylane, Radiesse and Sculptra, along with laser services, and dates its work to 2007. It names Stephanie Klein, NP, and says it has board-certified physicians and physician assistants. On Google it holds a 4.8-star rating across 384 reviews dating back to 2022, with 59 posted in the past year. Reviewers most often mention the staff and the providers' knowledge, with 28 and 25 mentions, and 11 mention results.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | Yes |
| Accepts insurance — per practice website | — |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-23. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★4.8 across 384 Google reviews. Of the 68 reviews we analyzed, 67 (99%) are positive (4–5★) and 1 (1%) are negative (1–2★).
What patients like
- Friendly, helpful staff27 reviews
- Knowledgeable, professional providers23 reviews
- Weight-loss results10 reviews
- Easy scheduling and communication7 reviews
Common complaints
Very few complaints — only 1 negative review, with no recurring theme.
Most recent Google reviews
Maxine R.★★★★★2026-09-23This is an excellent provider of aesthetic services. Staff are professional and caring.
Kathleen P.★★★★★2026-09-22Great customer service and very helpful responses to my questions.
jackie w.★★★★★2026-09-15Nicole is such a pro - she got me in and out quickly and always does perfect work.
Andrew★★★★★2026-09-10Wow! This was my first time getting laser treatment done. The staff was friendly and service was swift. Absolutely recommend.
Sheena★★★★★2026-09-02Everyone is so great and professional. They always accommodate my schedule and I leave feeling so great 👍🏻
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs